Company Info
Year Established2018
Ticker
ABBC
Exchange
NYSE
Contacts
Ron RenaudPresident & CEO
Raymond Sanchez, M.D.
CMO
John Renger, Ph.D.
CSO
Scott M. Akamine
CLO
Paul Burgess
CBO
Company Description
Cerevel Therapeutics, an AbbVie company, is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases.
